Telix Pharmaceuticals Ltd (TLX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TLX Annual Balance Sheets →
Balance sheet data covering Telix Pharmaceuticals Ltd–Dec 31 2024 offers a view into how Dec 31 2025's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents141.87
Current Tax Assets Current6.04
Cash & Short-term Investments147.00
Notes Receivable, Current37.08
Other Current Assets0.00
Total Current Assets330.28
Equipment/Property/Plant Net58.66
Goodwill net198.99
Intangible Assets592.82
Deferred Tax Assets59.35
Intangible AssetsAnd Goodwill69.17
Total Assets1,163.99
Liabilities
Accounts Payable150.35
Short-term Debt391.91
Current Provisions0.56
Total Current Liabilities231.62
Long-term debt3.52
Total Long-term Debt3.52
Deferred Tax Liabilities, Net LI44.71
Noncurrent Provisions157.56
Total Liabilities748.61
Stockholders' Equity
Other Equity415.38
Common Stockholder's Equity415.38
Total Stockholder's Equity415.38
Liabilities & Stockholder's Equity1,163.99
4 historic quarters locked

Sign in to unlock the full Telix Pharmaceuticals Ltd balance sheet history.

About Telix Pharmaceuticals Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 19, 2026
  • Source: tlx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-009943

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.